CLINICAL RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The aim of the study was to analyze the risk of all-cause mortality among middle-aged and older adults with chronic obstructive pulmonary disease (COPD) in China.

Material and methods:
Data were retrieved from the Chinese Longitudinal Healthy Longevity Survey (CLHLS) and the China Health and Retirement Longitudinal Study (CHARLS). COPD-related information was extracted to establish a longitudinal cohort study. A total of 17,988 participants who met the inclusion criteria were ultimately included in the analysis.

Results:
Significant differences in baseline characteristics were observed between the CLHLS and CHARLS cohorts (p < 0.001). Pearson correlation analysis indicated that COPD prevalence was positively associated with sex, age, educational level, marital status, multiple comorbidities, and smoking (p < 0.05). Kaplan–Meier survival analysis demonstrated significant differences in survival curves according to cohort, survival age, baseline COPD, newly diagnosed COPD, and total COPD (p < 0.05), whereas no significant difference was found between sexes (p > 0.05). Cox proportional hazards regression showed that female sex, older age, baseline COPD, lower educational level, marital status, and smoking were significantly associated with COPD-specific mortality (p < 0.05), while residence, alcohol consumption, and exercise were not significantly associated (p > 0.05).

Conclusions:
Older age, male sex, smoking, lower educational level, and long-term widowhood are associated with a higher risk of COPD-specific mortality among middle-aged and older adults with COPD.
REFERENCES (33)
1.
Zhuang M, Hassan II, W Ahmad WMA, et al. Effectiveness of digital health interventions for chronic obstructive pulmonary disease: systematic review and meta-analysis. J Med Internet Res 2025; 26: e76323.
 
2.
Clark SN, Anenberg SC, Brauer M. Global burden of disease from environmental factors. Annu Rev Public Health 2025; 46: 233-51.
 
3.
Ke Y, Zhao Y, Sun D, et al.; China Kadoorie Biobank Collaborative Group. All-cause and cause-specific mortality in individuals with COPD in China: a 16-year follow-up cohort study. Eur J Epidemiol 2025; 40: 681-91.
 
4.
Liu X, Xu J, Wang S. The role of chronic obstructive pulmonary disease mediated by immune cells on lung adenocarcinoma: a two-step, two-sample Mendelian randomization study. Medicine 2025; 104: e45248.
 
5.
Zhang Y, Chen XF, Chen XF, et al. A prospective study of the effect of physical activity on mortality risk in patients with chronic obstructive pulmonary disease in Sichuan Province. Chin Med J 2025; 46: 1347-53.
 
6.
Zhang S, Lan Y, Sun D, et al. Prospective association between physical activity and mortality in patients with chronic obstructive pulmonary disease. Beijing Da Xue Xue Bao Yi Xue Ban 2025; 57: 537-44.
 
7.
Dai L, Tang Y, Guo Y, Lai X, Wang X, Li B. The association between exercise, activities, and frailty in older Chinese adults: a cross-sectional study based on the Chinese Longitudinal Healthy Longevity Survey (CLHLS) data. BMC Geriatr 2025; 25: 131-40.
 
8.
Zhao X, Wang Y, Li J, et al. A machine-learning-derived online prediction model for depression risk in COPD patients: a retrospective cohort study from CHARLS. J Affect Disord 2025; 15: 284-93.
 
9.
Lipson DA, Crim C, Criner GJ, et al. Reduction in all-cause mortality with fluticasone furoate/umeclidinium/vilanterol in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2020; 201: 1508-16.
 
10.
Whittaker H, Rubino A, Müllerová H, et al. Frequency and severity of exacerbations of COPD associated with future risk of exacerbations and mortality: a UK Routine Health Care Data Study. Int J Chron Obstruct Pulmon Dis 2022; 3: 427-37.
 
11.
Zhang Y, Tan X, Hu S, Cui Z, Chen W. Relationship between systemic immune-inflammation index and risk of respiratory failure and death in COPD: a retrospective cohort study based on the MIMIC-IV database. Int J Chron Obstruct Pulmon Dis 2024; 19: 459-73.
 
12.
Robichaux C, Aron J, Wendt CH, et al. Sociodemographic and geographic risk factors for all-cause mortality in patients with COPD. Int J Chron Obstruct Pulmon Dis 2023; 25: 1587-93.
 
13.
Wong MS, Steers WN, Hoggatt KJ, Ziaeian B, Washington DL. Relationship of neighborhood social determinants of health on racial/ethnic mortality disparities in US veterans-Mediation and moderating effects. Health Serv Res 2020; 55 (Suppl 2): 851-62.
 
14.
Galiatsatos P, Woo H, Paulin LM, et al. The association between neighborhood socioeconomic disadvantage and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2020; 5: 981-93.
 
15.
Lee H, Lee BY, Jung J, et al. Association of socioeconomic status with respiratory mortality and hospitalisations in COPD: a nationwide cohort study. BMJ Open Respir Res 2025; 12: e003128.
 
16.
Wong CG, Miller JB, Zhang F, et al.; HABS-HD Study Team. Evaluation of neighborhood-level disadvantage and cognition in Mexican American and non-Hispanic white adults 50 years and older in the US. JAMA Netw Open 2023; 6: e2325325.
 
17.
Graul EL, Nordon C, Rhodes K, et al. Temporal risk of nonfatal cardiovascular events after chronic obstructive pulmonary disease exacerbation: a population-based study. Am J Respir Crit Care Med 2024; 209: 960-72.
 
18.
Wise RA, Chapman KR, Scirica BM, Daoud SZ, Lythgoe D, Garcia-Gil E. The impact of exacerbation history on the safety and efficacy of aclidinium in patients with chronic obstructive pulmonary disease and increased cardiovascular risk: ASCENT-COPD trial. Int J Chron Obstruct Pulmon Dis 2021; 18: 689-99.
 
19.
Zou W, Ou J, Wu F, et al. Association of mild chronic obstructive pulmonary disease with all-cause mortality: a systematic review and meta-analysis. Pulmonology 2025; 31: 2416813.
 
20.
Perez-Padilla R, Wehrmeister FC, de Oca MM, et al. Outcomes for symptomatic non-obstructed individuals and individuals with mild (GOLD stage 1) COPD in a population based cohort. Int J Chron Obstruct Pulmon Dis 2018; 26: 3549-61.
 
21.
Zhao G, Wang L, Lei S, Li Y, Li J, Feng Z. All-cause and cause-specific mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 2025; 30: 4173-90.
 
22.
Buttery SC, Zysman M, Vikjord SAA, Hopkinson NS, Jenkins C, Vanfleteren LEGW. Contemporary perspectives in COPD: patient burden, the role of gender and trajectories of multimorbidity. Respirology 2021; 26: 419-41.
 
23.
GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403: 2100-32.
 
24.
Zou J, Sun T, Song X, et al. Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data. Respir Res 2022; 23: 90-106.
 
25.
Chen S, Kuhn M, Prettner K, et al. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study. Lancet Glob Health 2023; 11: e1183-93.
 
26.
Hurst JR, Han MK, Singh B, et al. Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review. Respir Res 2022; 23: 213-35.
 
27.
Joshi P, Kim WJ, Lee SA. The effect of dietary antioxidant on the COPD risk: the community-based KoGES (Ansan-Anseong) cohort. Int J Chron Obstruct Pulmon Dis 2015; 8: 2159-68.
 
28.
Kim CY, Kim BK, Kim YJ, Lee SH, Kim YS, Kim JH. Longitudinal evaluation of the relationship between low socioeconomic status and incidence of chronic obstructive pulmonary disease: Korean Genome and Epidemiology Study (KoGES). Int J Chron Obstruct Pulmon Dis 2021; 5: 3447-54.
 
29.
Dong Y, Hu Q. Association between frailty and frailty change with chronic lung disease: results from two prospective cohort studies. BMC Public Health 2025; 25: 2283-92.
 
30.
Lee H, Jung J, Yoon HY. Impact of socioeconomic status on chronic obstructive pulmonary disease prognosis: a national cohort study. Front Med 2025; 4: 1584945.
 
31.
de la Rosa-Carrillo D, de Granda-Orive JI, Diab Cáceres L, et al. The impact of smoking on bronchiectasis and its comorbidities. Expert Rev Respir Med 2024; 18: 255-68.
 
32.
Wang Z, Qiu Y, Ji X, Dong L. Effects of smoking cessation on individuals with COPD: a systematic review and meta-analysis. Front Public Health 2024; 11: 1433269.
 
33.
Huang HY, Chen CL, Lin YL, et al. Optimizing treatment for hospitalized patients with COPD: a study on the impact of a LINE App-based multidisciplinary team approach targeting pharmacological treatment, lifestyle changes, and smoking cessation. Int J Chron Obstruct Pulmon Dis 2025; 18: 1149-59.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top